Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Healthcare.com has introduced Autopilot, an AI-powered platform designed to enhance health insurance distribution by matching consumers with distributors using proprietary data.
VisiQuate has acquired Rotera to strengthen its AI-driven revenue cycle management capabilities, enhancing automation in healthcare.
Health In Tech has announced a collaboration with DialCare to integrate virtual primary care and behavioral health services into its health plan offerings, enhancing access to affordable healthcare.
NodeAI, a startup from Hamilton, Ontario, has won the Falcons' Fortunes 2025 competition for its AI-driven lung cancer diagnostics technology.
Prendio-BioProcure has launched new AI-driven capabilities to streamline procurement processes for biotech companies, enhancing efficiency and cost savings.
Arlo has announced $4 million in seed funding to enhance its AI-driven health insurance solutions for small businesses, with support from Upfront Ventures, 8VC, and General Catalyst.
XRP Healthcare has announced plans to go public by Q3 2025, accelerating its AI and M&A strategies, according to a press release.
Navina has raised $55 million in a Series C funding round led by Goldman Sachs Alternatives, aiming to expand its AI-powered clinical intelligence platform.
AIRA Matrix and Gestalt Diagnostics have partnered to integrate AI-driven quality control into pathology workflows, enhancing diagnostic precision and efficiency.
Avatar Medical has received FDA 510(k) clearance for its brAIn SPS, a shoulder positioning system developed with FX Shoulder Solutions, enhancing preoperative planning with AI-driven imaging.
PhaseV will showcase its new AI/ML-powered clinical trial design and analysis capabilities at the CMO Summit 360° in Boston, enhancing trial success prediction and planning.
Gestalt Diagnostics has announced a global reseller partnership with DLS Pathology Services to expand its digital pathology solutions in Australia and beyond.
Noul Co., Ltd. presented its AI-powered cervical cancer screening technology at NVIDIA GTC 2025, highlighting its miLab™ CER platform.
Brainomix has completed an $18 million Series C funding round to advance its AI imaging technology for stroke and lung fibrosis, with plans to expand in the US.
Pearl and Medit have announced a partnership to integrate AI-powered diagnostic solutions into the Medit Link platform, enhancing dental diagnostics and patient communication.
Gestalt and Primaa have announced a strategic partnership to integrate AI technology for skin cancer diagnosis into Gestalt's PathFlow platform, enhancing diagnostic precision and workflow efficiency.
Olio Labs has released a study revealing why women experience stronger side effects from GLP-1 drugs, highlighting sex-based differences in drug response.
Myant has launched Care360, an AI-driven cardiac assessment service aimed at making specialist cardiac care more accessible and preventive, according to a press release.
Tech Mahindra has announced a new pharmacovigilance solution developed with NVIDIA AI software to enhance drug safety management.
Digital Diagnostics' AI platform was recognized by NVIDIA at GTC 2025 for its role in enhancing diagnostic accuracy and accessibility in healthcare.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
